Tyers Asset Management’s Acceleron Pharma XLRN Stock Holding History

Tyers Asset Management’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$21K	Sell	528 -80	-13%	-$3.47K	﹤0.01%	951
2019 Q2	$25K	Sell	608 -4,528	-88%	-$187K	﹤0.01%	954
2019 Q1	$239K	Sell	5,136 -32	-0.6%	-$1.41K	0.01%	667
2018 Q4	$225K	Sell	5,168 -3,824	-43%	-$191K	0.01%	649
2018 Q3	$515K	Sell	8,992 -176	-2%	-$8.65K	0.02%	467
2018 Q2	$445K	Buy	9,168 +1,008	+12%	+$36.7K	0.02%	469
2018 Q1	$319K	Buy	+8,160	New	+$347K	0.01%	544

Other funds holding XLRN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Tyers Asset Management's XLRN Position: Q3 2019 in Review

Tyers Asset Management reduced its Acceleron Pharma (XLRN) stake by 13% in Q3 2019, selling an estimated $3.47K and leaving 528 shares worth $21K. The position accounts for ﹤0.01% of the portfolio, ranked #951.

Tyers Asset Management first reported a position in XLRN in Q1 2018 and has held it in 7 quarters since. The position peaked at $515K in Q3 2018. 172 funds tracked by Wall St. Rank hold XLRN as of Q3 2019.

Tyers Asset Management held 528 shares of Acceleron Pharma worth $21K as of Q3 2019.
Tyers Asset Management sold 80 Acceleron Pharma shares in Q3 2019, an estimated $3.47K.
Acceleron Pharma made up ﹤0.01% of Tyers Asset Management's portfolio in Q3 2019, its #951 holding.
Tyers Asset Management first reported a position in Acceleron Pharma in Q1 2018 and has held it in 7 quarters since.
Tyers Asset Management's Acceleron Pharma position peaked at $515K in Q3 2018.
172 funds tracked by Wall St. Rank held Acceleron Pharma as of Q3 2019.

Based on Tyers Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.